Press Release n°15-2024 - A new IT system to streamline the management of Pharmacovigilance Funds, which are essential for the functioning of the Regional Centres and for the implementation of active pharmacovigilance projects, thus promoting knowledge of the benefit-risk profile of medicines after their marketing, in real conditions of use.

The new system developed by the Italian Medicines Agency will be accessible to the Regions from 1 October, after the presentation and training event held today at the Agency.

“From a system in which everything is still entered manually, with the inevitable slowdown in data management and monitoring activity, we are moving to an innovative digital platform that will allow us to improve the efficiency of the use of financial resources, allowing for simpler and more traceable management”, explains Anna Rosa Marra, head of AIFA's Post Marketing Surveillance Division.
In more detail, the system allows:

• enter technical and economic data in a standardised way, making it easier to share and analyse information; 
• track each activity and its communication, so as to have constant control over each stage of the process;
• monitor financed activities, with automatic notifications reminding of deadlines.

“The implementation of the IT System for the Management of Pharmacovigilance Funds represents an important turning point in the management of public resources for the post-marketing surveillance of medicines”, says Anna Rosa Marra. “I am certain” she concludes – “that this platform will allow the Regions and AIFA to work in a more coordinated way, improving the effectiveness of pharmacovigilance activity, which is fundamental in terms of safety and optimal use of medicines”.